Aurobindo Pharma Limited (NSE:AUROPHARMA)
India
· Delayed Price · Currency is INR 1,217.60
-5.50 (-0.45%)
At close: Dec 5, 2025
Aurobindo Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 707,184 | 674,020 | 637,941 | 303,575 | 391,729 | 516,388 | Upgrade
|
| Market Cap Growth | -1.44% | 5.66% | 110.14% | -22.50% | -24.14% | 113.31% | Upgrade
|
| Enterprise Value | 696,132 | 689,676 | 632,994 | 283,996 | 394,408 | 532,915 | Upgrade
|
| Last Close Price | 1217.60 | 1156.16 | 1084.68 | 513.88 | 653.35 | 855.63 | Upgrade
|
| PE Ratio | 20.66 | 19.34 | 20.11 | 15.75 | 14.79 | 9.68 | Upgrade
|
| Forward PE | 17.71 | 15.91 | 17.77 | 12.19 | 12.83 | 14.88 | Upgrade
|
| PS Ratio | 2.17 | 2.13 | 2.20 | 1.22 | 1.67 | 2.08 | Upgrade
|
| PB Ratio | 2.02 | 2.07 | 2.14 | 1.13 | 1.59 | 2.36 | Upgrade
|
| P/TBV Ratio | 2.31 | 2.36 | 2.46 | 1.31 | 1.85 | 2.73 | Upgrade
|
| P/FCF Ratio | 19.52 | 34.45 | - | - | 13.22 | 27.31 | Upgrade
|
| P/OCF Ratio | 11.49 | 17.17 | 26.20 | 12.72 | 7.81 | 15.51 | Upgrade
|
| PEG Ratio | 1.54 | 1.36 | 0.78 | 1.63 | 2.09 | 1.35 | Upgrade
|
| EV/Sales Ratio | 2.14 | 2.17 | 2.18 | 1.14 | 1.68 | 2.15 | Upgrade
|
| EV/EBITDA Ratio | 10.58 | 10.72 | 10.98 | 7.81 | 9.15 | 9.88 | Upgrade
|
| EV/EBIT Ratio | 13.90 | 13.83 | 14.41 | 11.31 | 11.93 | 11.97 | Upgrade
|
| EV/FCF Ratio | 19.21 | 35.25 | - | - | 13.31 | 28.18 | Upgrade
|
| Debt / Equity Ratio | 0.22 | 0.25 | 0.22 | 0.20 | 0.12 | 0.24 | Upgrade
|
| Debt / EBITDA Ratio | 1.18 | 1.27 | 1.14 | 1.43 | 0.65 | 0.97 | Upgrade
|
| Debt / FCF Ratio | 2.15 | 4.22 | - | - | 0.96 | 2.82 | Upgrade
|
| Asset Turnover | 0.65 | 0.67 | 0.68 | 0.67 | 0.69 | 0.79 | Upgrade
|
| Inventory Turnover | 1.27 | 1.33 | 1.42 | 1.45 | 1.26 | 1.22 | Upgrade
|
| Quick Ratio | 0.95 | 0.99 | 0.96 | 0.98 | 1.10 | 0.90 | Upgrade
|
| Current Ratio | 1.85 | 1.85 | 1.98 | 1.88 | 2.22 | 1.86 | Upgrade
|
| Return on Equity (ROE) | 10.38% | 11.15% | 11.18% | 7.50% | 11.39% | 27.53% | Upgrade
|
| Return on Assets (ROA) | 6.25% | 6.57% | 6.46% | 4.25% | 6.10% | 8.87% | Upgrade
|
| Return on Capital (ROIC) | 7.66% | 8.05% | 8.00% | 5.27% | 7.56% | 11.13% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.60% | 14.20% | 13.40% | 8.80% | 12.80% | 19.20% | Upgrade
|
| Earnings Yield | 4.84% | 5.17% | 4.97% | 6.35% | 6.76% | 10.33% | Upgrade
|
| FCF Yield | 5.12% | 2.90% | -0.54% | -0.06% | 7.56% | 3.66% | Upgrade
|
| Dividend Yield | 0.65% | - | 0.41% | 0.58% | 1.38% | 0.47% | Upgrade
|
| Payout Ratio | 6.79% | 0.03% | 8.31% | 22.80% | 9.96% | 4.39% | Upgrade
|
| Buyback Yield / Dilution | 0.58% | 0.52% | - | - | - | - | Upgrade
|
| Total Shareholder Return | 1.24% | 0.52% | 0.41% | 0.58% | 1.38% | 0.47% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.